🔍 Analysis: Strategic Partnership: NASDAQ:OPCH has entered a multi-year commercial partnership with Palantir to enhance patient outcomes and operational efficiency through data integration. Cost Reduction: The collaboration aims to reduce costs and improve margins by streamlining operations. Institutional Interest: Increased interest from institutional firms...
This is just my basic MONTHLY charting. I have marked what I see as the POSSIBLE bottom (support). I see overall DOWNTREND with Possible reversal. I have marked my potential BUY/SELL LEVELS for LONGS/SHORTS/CALLS/PUTS.
Break below 25.90 , possible stop at 27.13. First target 23.13, Second target 20.17.